Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
Authors
Keywords
-
Journal
MMWR Recommendations and Reports
Volume 70, Issue 6, Pages 1-16
Publisher
Centers for Disease Control MMWR Office
Online
2021-12-17
DOI
10.15585/mmwr.rr7006a1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Analysis of hospitalized and severe dengue cases over the six-years of follow-up of the tetravalent dengue vaccine (CYD-TDV) efficacy trials in Asia and Latin America
- (2021) Rémi Forrat et al. CLINICAL INFECTIOUS DISEASES
- Immunogenicity and safety of a tetravalent dengue vaccine and a bivalent HPV vaccine given concomitantly or sequentially in girls aged 9 to 14 years in Mexico
- (2021) Jose Luis Arredondo et al. VACCINE
- Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Quadrivalent Human Papillomavirus Vaccine in Boys and Girls 9–13 Years of Age in Malaysia
- (2021) Jamiyah Hassan et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine
- (2021) Jaime Santos et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Target product profile for a dengue pre-vaccination screening test
- (2021) Noah Fongwen et al. PLoS Neglected Tropical Diseases
- Cost-effectiveness of dengue vaccination in Puerto Rico
- (2021) Guido España et al. PLoS Neglected Tropical Diseases
- Travel-Associated and Locally Acquired Dengue Cases — United States, 2010–2017
- (2020) Aidsa Rivera et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial
- (2020) Shibadas Biswal et al. LANCET
- Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus
- (2020) Gustavo H. Dayan et al. VACCINE
- Zika virus infection enhances future risk of severe dengue disease
- (2020) Leah C. Katzelnick et al. SCIENCE
- Dengue vaccine development by the year 2020: challenges and prospects
- (2020) Annelies Wilder-Smith Current Opinion in Virology
- Optimising dengue pre-vaccination screening
- (2020) Annelies Wilder-Smith et al. LANCET INFECTIOUS DISEASES
- Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9–50 years (CYD65): a randomised, controlled, phase 2, non-inferiority study
- (2020) Diana Leticia Coronel-MartÍnez et al. LANCET INFECTIOUS DISEASES
- Correction: Alternative strategies for mosquito-borne arbovirus control
- (2019) Nicole L. Achee et al. PLoS Neglected Tropical Diseases
- An agent-based model of dengue virus transmission shows how uncertainty about breakthrough infections influences vaccination impact projections
- (2019) T. Alex Perkins et al. PLoS Computational Biology
- Dengue pre-vaccination screening and positive predictive values
- (2019) Isabel Rodríguez-Barraquer et al. LANCET INFECTIOUS DISEASES
- Dengue
- (2019) Annelies Wilder-Smith et al. LANCET
- Sensitivity and negative predictive value for a rapid dengue test
- (2019) Stefan Flasche et al. LANCET INFECTIOUS DISEASES
- Yellow fever (YF) vaccination does not increase dengue severity: A retrospective study based on 11,448 dengue notifications in a YF and dengue endemic region
- (2019) Marina Jolli Luppe et al. Travel Medicine and Infectious Disease
- The current and future global distribution and population at risk of dengue
- (2019) Jane P. Messina et al. Nature Microbiology
- Severe dengue in travellers: pathogenesis, risk and clinical management
- (2019) Scott Halstead et al. JOURNAL OF TRAVEL MEDICINE
- Prolonged persistence of IgM against dengue virus detected by commonly used commercial assays
- (2018) Yu-Wen Chien et al. BMC INFECTIOUS DISEASES
- Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
- (2018) Saranya Sridhar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005–2014)
- (2018) Maïna L’Azou et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Immunogenicity and Safety of a Booster Injection of DTap-IPV//Hib (Pentaxim) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers 15–18 Months of Age in Mexico
- (2017) Flor Irene Rodriguez Melo et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immune-mediated cytokine storm and its role in severe dengue
- (2017) Anon Srikiatkhachorn et al. Seminars in Immunopathology
- CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety
- (2017) Isabella Piassi Godói et al. Journal of Comparative Effectiveness Research
- Dengue virus compartmentalization during antibody-enhanced infection
- (2017) Eugenia Z. Ong et al. Scientific Reports
- Current management of severe dengue infection
- (2016) Tau Hong Lee et al. Expert Review of Anti-Infective Therapy
- Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America
- (2016) Gustavo Olivera-Botello et al. JOURNAL OF INFECTIOUS DISEASES
- Knockdown Resistance Mutations in Aedes aegypti (Diptera: Culicidae) From Puerto Rico
- (2016) Gustavo Ponce-García et al. JOURNAL OF MEDICAL ENTOMOLOGY
- Evidence-based risk assessment and communication: a new global dengue-risk map for travellers and clinicians#
- (2016) Emily S. Jentes et al. JOURNAL OF TRAVEL MEDICINE
- The global economic burden of dengue: a systematic analysis
- (2016) Donald S Shepard et al. LANCET INFECTIOUS DISEASES
- The global burden of dengue: an analysis from the Global Burden of Disease Study 2013
- (2016) Jeffrey D Stanaway et al. LANCET INFECTIOUS DISEASES
- Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) When Administered Concomitantly With a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12–13 Months of Age in Colombia and Peru
- (2016) Pio López et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study
- (2016) Stefan Flasche et al. PLOS MEDICINE
- The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis
- (2016) Dustin R. Glasner et al. Annual Review of Virology
- Incidence of Dengue Virus Infection in School-Aged Children in Puerto Rico: A Prospective Seroepidemiologic Study
- (2015) D. Fermín Argüello et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
- (2015) Stephen S. Whitehead Expert Review of Vaccines
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- First Experience of Concomitant Vaccination Against Dengue and MMR in Toddlers
- (2015) Denis Crevat et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Research on Dengue During World War II Revisited
- (2014) Grace E. Snow et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Epidemiological Risk Factors Associated with High Global Frequency of Inapparent Dengue Virus Infections
- (2014) Laura Grange et al. Frontiers in Immunology
- Clinical Characteristics of Dengue Shock Syndrome in Vietnamese Children: A 10-Year Prospective Study in a Single Hospital
- (2013) Phung Khanh Lam et al. CLINICAL INFECTIOUS DISEASES
- A Shorter Time Interval Between First and Second Dengue Infections Is Associated With Protection From Clinical Illness in a School-based Cohort in Thailand
- (2013) Kathryn B. Anderson et al. JOURNAL OF INFECTIOUS DISEASES
- Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore
- (2013) Anke Harenberg et al. Human Vaccines & Immunotherapeutics
- Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year
- (2013) Magelda Montoya et al. PLoS Neglected Tropical Diseases
- Factors contributing to the disturbance of coagulation and fibrinolysis in dengue virus infection
- (2012) Yung-Chun Chuang et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Preexisting Japanese Encephalitis Virus Neutralizing Antibodies and Increased Symptomatic Dengue Illness in a School-Based Cohort in Thailand
- (2011) Kathryn B. Anderson et al. PLoS Neglected Tropical Diseases
- Septic tanks as larval habitats for the mosquitoes Aedes aegypti and Culex quinquefasciatus in Playa-Playita, Puerto Rico
- (2010) R. BURKE et al. MEDICAL AND VETERINARY ENTOMOLOGY
- Unusual productivity of Aedes aegypti in septic tanks and its implications for dengue control
- (2008) R. BARRERA et al. MEDICAL AND VETERINARY ENTOMOLOGY
- Projected Cost-effectiveness of New Vaccines for Adolescents in the United States
- (2008) Ismael R. Ortega-Sanchez et al. PEDIATRICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More